Expression of a functional single-chain Fv antibody on the surface of Streptococcus gordonii
Gram-positive bacterium Streptococcus gordonii, a human oral commensal, was engineered to display a single-chain Fv (scFv) antibody fragment at the cell surface. The previously developed host-vector system allowed expression of the Guy’s 13 scFv as a fusion with the streptococcal surface protein M6. Surface expression of the 515-amino acid M6/scFv fusion protein was confirmed by Western blot analysis on cellular fractions and flow cytometric analysis. Guy’s 13 scFv was derived from the Guy’s 13 monoclonal antibody, which was raised against streptococcal antigen I/II (SA I/II), the major adhesin of the caries-producing bacterium Streptococcus mutans. Surface plasmon resonance was used to test binding of scFv-expressing S. gordonii to SA I/II. Whole cells of recombinant S. gordonii were found to specifically bind to immobilised SA I/II and binding was inhibited by fluid-phase SA I/II in a dose-dependent manner. Production of a functional scFv in S. gordonii is the first step towards the development of genetically engineered commensal bacteria that, by colonizing mucosal surfaces, may provide the host with sustained delivery of recombinant antibodies.
Index EntriesEngineered Gram-positive bacteria recombinant proteins surface display single-chain Fv antibody fragments surface plasmon resonance binding activity
Unable to display preview. Download preview PDF.
- 1.Pozzi, G. and Wells, J. M. (1997) Gram-positive Bacteria. Vaccine Vehicles for Mucosal Immunization. Landes Bioscience, Austin, TX, USA.Google Scholar
- 10.Oggioni, M. R., Beninati, C., Boccanera, M., et al. (2001) Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody. Int. Rev. Immunol. 20(2), 267–269.Google Scholar
- 14.Pozzi, G., M. R. Oggioni, and Medaglini, D. (1997) Recombinant Streptococcus gordonii as live vehicle for vaccine antigens, in Gram-positive Bacteria. Vaccine Vehicles for Mucosal Immunization. Pozzi, G. and Wells, J. M., eds., Springer-Verlag, Berlin, Germany and Landes Bioscience, Georgetown, TX, pp. 35–60.Google Scholar
- 15.Medaglini, D., Pozzi, G., King, T. P. and Fischetti, V. A. (1995) Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc. Natl. Acad. Sci. USA 92(15), 6868–6872.PubMedCrossRefGoogle Scholar
- 16.Medaglini, D., Rush, C. M., Sestini, P. and Pozzi, G. (1997) Commensal bacteria as vehicles for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci includes local and systemic antibodies in mice. Vaccine 15(12–13), 1330–1337.PubMedCrossRefGoogle Scholar
- 30.Holmes, S. D., May, K., Johansson, V., Markey, F. and Critchley, I. A. (1997) Studies on the interaction of Staphylococcus aureus and Staphylococcus epidermis with fibronectin using surface plasmon resonance (BIAcore). J. Immunol. Methods. 28, 77–84.Google Scholar
- 36.Pozzi, G., M. R. Oggioni, R. Manganelli, and Plevani, P. (1990) Genetic exchange and heterologous gene expression in streptococci: the bacterial chromosome as vector of recombinant DNA molecules, in Recombinant DNA Technologies in Industry and Agriculture: State-of-Art in Italy. Amaldi, F., De Felice, M., Di Fonzo, N., Merlin, P., Polsinelli, A. and Viotti A. eds., Amity, Milano, pp. 45–48.Google Scholar